Muir AJ - Search Results

1

Ribavirin as maintenance therapy for hepatitis C patients: an interim peacekeeper?

Patel K, Dev A, Muir AJ, McHutchison JG. Patel K, et al. Among authors: muir aj. Hepatology. 2003 Jul;38(1):21-4. doi: 10.1053/jhep.2003.50326. Hepatology. 2003. PMID: 12829982 Review. No abstract available.

2

Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients.

Patel K, Muir AJ, McHutchison JG. Patel K, et al. Among authors: muir aj. Hepatology. 2003 May;37(5):1222; author reply 1222-3. doi: 10.1053/jhep.2003.50159. Hepatology. 2003. PMID: 12717404 No abstract available.

3

A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.

Patel K, Muir A, McHutchison JG, Patton HM. Patel K, et al. Am J Gastroenterol. 2003 May;98(5):952-5. doi: 10.1111/j.1572-0241.2003.07422.x. Am J Gastroenterol. 2003. PMID: 12809813 No abstract available.

4

Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection.

Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Condron SL, et al. Among authors: muir aj. Transplantation. 2005 Jul 15;80(1):145-8. doi: 10.1097/01.tp.0000164291.35925.7a. Transplantation. 2005. PMID: 16003247

5

Diagnosis and treatment of chronic hepatitis C infection.

Patel K, Muir AJ, McHutchison JG. Patel K, et al. Among authors: muir aj. BMJ. 2006 Apr 29;332(7548):1013-7. doi: 10.1136/bmj.332.7548.1013. BMJ. 2006. PMID: 16644828 Free PMC article. Review. No abstract available.

6

Growth factors during HCV therapy may be "cost-effective", but are they "effective"?

Muir AJ, McHutchison JG. Muir AJ, et al. Hepatology. 2006 Dec;44(6):1400-3. doi: 10.1002/hep.21426. Hepatology. 2006. PMID: 17133467 No abstract available.

7

Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia.

Canlas KR, Dobozi BM, Lin S, Smith AD, Rockey DC, Muir AJ, Agrawal NM, Poleski MH, Patel K, McHutchison JG. Canlas KR, et al. Among authors: muir aj. J Clin Gastroenterol. 2008 Aug;42(7):844-8. doi: 10.1097/MCG.0b013e318038d312. J Clin Gastroenterol. 2008. PMID: 18277884

8

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.

Lawitz E, Rodriguez-Torres M, Muir AJ, Kieffer TL, McNair L, Khunvichai A, McHutchison JG. Lawitz E, et al. Among authors: muir aj. J Hepatol. 2008 Aug;49(2):163-9. doi: 10.1016/j.jhep.2008.03.027. Epub 2008 Apr 29. J Hepatol. 2008. PMID: 18486984 Clinical Trial.

9

Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis C.

Nelson DR, Rustgi V, Balan V, Sulkowski MS, Davis GL, Muir AJ, Lambiase LR, Dickson RC, Weisner RH, Fiscella M, Cronin PW, Pulkstenis E, McHutchison JG, Subramanian GM. Nelson DR, et al. Among authors: muir aj. Clin Gastroenterol Hepatol. 2009 Feb;7(2):212-8. doi: 10.1016/j.cgh.2008.10.035. Epub 2008 Nov 7. Clin Gastroenterol Hepatol. 2009. PMID: 19061971 Clinical Trial.

10

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

McHutchison JG, Everson GT, Gordon SC, Jacobson IM, Sulkowski M, Kauffman R, McNair L, Alam J, Muir AJ; PROVE1 Study Team. McHutchison JG, et al. Among authors: muir aj. N Engl J Med. 2009 Apr 30;360(18):1827-38. doi: 10.1056/NEJMoa0806104. N Engl J Med. 2009. PMID: 19403902 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters